Alterity Therapeutics Statistics Share Statistics Alterity Therapeutics has 9.06M
shares outstanding. The number of shares has increased by 77.63%
in one year.
Shares Outstanding 9.06M Shares Change (YoY) 77.63% Shares Change (QoQ) 38.53% Owned by Institutions (%) 0% Shares Floating 8.63M Failed to Deliver (FTD) Shares 529 FTD / Avg. Volume 0.68%
Short Selling Information The latest short interest is 71.2K, so 0.39% of the outstanding
shares have been sold short.
Short Interest 71.2K Short % of Shares Out 0.39% Short % of Float 0.4% Short Ratio (days to cover) 4.91
Valuation Ratios The PE ratio is -0.86 and the forward
PE ratio is -4.76.
Alterity Therapeutics's PEG ratio is
0.1.
PE Ratio -0.86 Forward PE -4.76 PS Ratio 4.09 Forward PS 6.8 PB Ratio 1.19 P/FCF Ratio -1.3 PEG Ratio 0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alterity Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.54,
with a Debt / Equity ratio of 0.01.
Current Ratio 3.54 Quick Ratio 3.54 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $401.93K Profits Per Employee $-1.91M Employee Count 10 Asset Turnover 0.21 Inventory Turnover n/a
Taxes Income Tax 46.09K Effective Tax Rate -0.24%
Stock Price Statistics The stock price has increased by 200.75% in the
last 52 weeks. The beta is 0.36, so Alterity Therapeutics's
price volatility has been higher than the market average.
Beta 0.36 52-Week Price Change 200.75% 50-Day Moving Average 5.01 200-Day Moving Average 4.07 Relative Strength Index (RSI) 26.06 Average Volume (20 Days) 77,725
Income Statement In the last 12 months, Alterity Therapeutics had revenue of 4.02M
and earned -19.12M
in profits. Earnings per share was -3.12.
Revenue 4.02M Gross Profit 3.8M Operating Income -19.6M Net Income -19.12M EBITDA -19.57M EBIT -19.61M Earnings Per Share (EPS) -3.12
Full Income Statement Balance Sheet The company has 12.64M in cash and 159.04K in
debt, giving a net cash position of 12.48M.
Cash & Cash Equivalents 12.64M Total Debt 159.04K Net Cash 12.48M Retained Earnings -214.16M Total Assets 10.55M Working Capital 7.71M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.61M
and capital expenditures -5.72K, giving a free cash flow of -12.61M.
Operating Cash Flow -12.61M Capital Expenditures -5.72K Free Cash Flow -12.61M FCF Per Share -2.07
Full Cash Flow Statement Margins Gross margin is 94.67%, with operating and profit margins of -487.69% and -475.79%.
Gross Margin 94.67% Operating Margin -487.69% Pretax Margin -474.65% Profit Margin -475.79% EBITDA Margin -486.94% EBIT Margin -487.69% FCF Margin -313.78%
Dividends & Yields ATHE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ATHE is $12,
which is 200% higher than the current price. The consensus rating is "Strong Buy".
Price Target $12 Price Target Difference 200% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 9, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jan 9, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -29.66 Piotroski F-Score 2
